Hogan Lovells’ upcoming merger with Cadwalader will nearly double its New York-based revenue, putting that office nearly on par with its highest-grossing centers.

The National Institutes of Health is months behind on dispersing the bulk of its fiscal 2026 money to grantees, and research advocates worry that without an update on the delay the Trump administration will claw back the funds or create multiyear grants that hamstring the recipients.

The Environmental Protection Agency’s attorneys urged a federal appellate court at a Tuesday hearing to consider new evidence in its attempt to overturn a lower-court order that it regulate fluoride added to drinking water.

Less than a month after the US Food and Drug Administration said a TV advertisement for Novo Nordisk A/S’ Wegovy weight-loss pill included “false or misleading” claims, the company was hit with a notice for its original blockbuster Ozempic.

A group of former Wells Fargo & Co. employees failed to prove that high drug prices under the bank’s health plan violated its fiduciary duties, even though the price variations they identified were “staggering,” a federal judge in Minnesota ruled Tuesday.

A Mitre Corp. engineer with long-haul Covid was properly awarded more than $210,000 in disability benefits from Reliance Standard Life Insurance Co., the Fourth Circuit said in an opinion weighing ERISA’s claims procedures.